Summarized by Masters of Longevity from Fight Aging!.
Reports on an LNP-mRNA approach that programs native natural killer cells in vivo to express chimeric antigen receptors, enabling targeted immune responses against cancer and autoreactive T cells.
Key Takeaways
- Antibody‑coated lipid nanoparticles delivered mRNA that reprogrammed about 80% of targeted NK cells in mice.
- In a mouse melanoma model, three of five treated animals achieved complete remission after NK cell reprogramming.
- The LNP‑mRNA strategy also produced significant tumor clearance in a humanized mouse model of T cell lymphoma.
